Andrei Chernov
About Andrei Chernov
Andrei Chernov is a Director at Bristol Myers Squibb, with a background in consulting and business development analytics.
Current Position at Bristol Myers Squibb
Since May 2020, Andrei Chernov has been serving as a Director at Bristol Myers Squibb. In this role, he acts as a key point of contact for business development analytics, primarily within the cardiovascular, neurology, and immunology franchises. Chernov collaborates closely with commercial leaders, business development transactions and strategy & execution teams, R&D, and BD finance teams. His responsibilities include driving data-driven investment decisions and playing a significant role in strategic framing and due diligence processes.
Previous Experience at IQVIA
Andrei Chernov has significant experience in the healthcare consulting field through his time at IQVIA. From 2017 to 2020, he worked as an Engagement Manager, Consulting Services. Prior to this, he served as a Consultant in Real World Evidence from 2015 to 2017 in the Greater New York City Area. During his tenure, he gained valuable experience in consulting and real-world evidence, which laid the groundwork for his current role in business development analytics.
Education and MBA from The Tuck School of Business
Andrei Chernov undertook his Master of Business Administration (MBA) at The Tuck School of Business at Dartmouth, studying from 2013 to 2015. This advanced education equipped him with the skills and knowledge necessary for his subsequent roles in business development, strategy, and analytics. His MBA education has been fundamental in his career development, providing a solid grounding in business principles and strategic management.
Professional Background
Before his current role, Andrei Chernov accumulated diverse professional experiences. In the summer of 2014, he interned at Infosys as an MBA Summer Intern in the Greater Bengaluru Area. From 2012 to 2013, he managed projects as a Manager at EPAM Systems in Minsk, Belarus. These roles offered him exposure to different facets of business and technology management, laying the foundation for his expertise in managing and executing business strategies.
Role in Investment Decision Analytics
At Bristol Myers Squibb, Andrei Chernov focuses on fit-for-purpose analytics to support investment decisions. His role involves detailed analysis to support the company's investment strategy within the cardiovascular, neurology, and immunology franchises. By leveraging data-driven insights, he ensures that investment decisions are well-founded and strategically aligned with the company's long-term goals.